Counterfeit medicines on the rise
June 1, 2004The World Health Organisation (WHO) estimates that up to 10% of medicines worldwide may be counterfeit, costing the pharmaceutical industry …
Making the most of your talent
May 27, 2004The vast majority of pharma executives would argue that having a large number of products in any company's portfolio should …
Roche prescribing data to support NICE uptake
May 27, 2004Roche is to provide NICE with regular updates on patient access to its treatments to help increase the uptake of …
NICE strikes deal with industry on data confidentiality
May 26, 2004The industry and NICE have reached agreement on how the cost and clinical effectiveness body can meet demands for transparency …
The downside to downsizing
May 24, 2004It used to be that the pharmaceutical industry was virtually recession-proof. When times were bad, the unemployed had more time …
Sanofi takes charge of arranged marriage
May 24, 2004Sanofi-Synthelabo chief executive Jean-Francois Dehecq is preparing his company to merge with larger Franco-German neighbours Aventis to create the world's …
Velcade launched in UK
May 24, 2004Velcade, the first in a new class of cancer drugs has been launched in the UK as a third line …
UCB snaps up arthritis drug and Celltech in one
May 20, 2004Brussels-based UCB is to buy the UK's number one biotech company Celltech for around $1.5 billion, creating the world's fifth …
AstraZeneca issues Crestor safety warning
May 20, 2004AstraZeneca has written to healthcare professionals in the UK after a small number of patients reported serious side effects after …
Addressing the gender divide
May 20, 2004A recent report by the Equal Opportunity Commission (EOC), Promoting Gender Equality in Health, has highlighted a significant omission which …
GSK establishes strategic link with Theravance
May 20, 2004GlaxoSmithKline has paid $129 million to a small US biotech company for a three-year worldwide licensing option on all the …
European biotech revenues fall back
May 20, 2004Revenues from the European biotech sector have fallen back for the first time in 2003, as many companies across the …
Faslodex launched in UK
May 19, 2004AstraZeneca, Faslodex
The latest addition to AstraZeneca’s oncology franchise, breast cancer drug Faslodex has been launched in the UK.Licensed for the treatment …
Obesity drug collaboration for BMS and Solvay
May 19, 2004Bristol-Myers Squibb and Solvay are to collaborate on the development and marketing of a novel phase I compound for the …
NICE strikes deal with industry on data confidentiality
May 19, 2004The industry and NICE have reached agreement on how the cost and clinical effectiveness body can meet demands for transparency …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
